Second opinion and self-efficacy in German skin cancer patients.

Autor: Stege H; Department of Dermatology, University Medical Center Mainz, Mainz, Germany., Schneider S; Department of Dermatology, University Medical Center Mainz, Mainz, Germany., Forschner A; Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany., Eigentler T; Department of Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany., Nashan D; Department of Dermatology, Hospital Dortmund, Dortmund, Germany., Huening S; Department of Dermatology, Hospital Dortmund, Dortmund, Germany., Lehr S; Department of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany., Meiss F; Department of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany., Kaatz M; Department of Dermatology, DRK-Krankenhaus Rabenstein, Chemnitz, Germany., Kuchen R; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center, Mainz, Germany., Kaehler KC; Department of Dermatology, Venerology and Allergology, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany., Haist M; Department of Dermatology, University Medical Center Mainz, Mainz, Germany., Grabbe S; Department of Dermatology, University Medical Center Mainz, Mainz, Germany., Huebner J; Klinik für Innere Medizin II, Hämatologie und Onkologie, Universitätsklinikum Jena, Jena, Germany., Loquai C; Department of Dermatology, University Medical Center Mainz, Mainz, Germany.; Department of Dermatology, Klinikum Bremen-Ost, Gesundheitnord gGmbH Bremen, Bremen, Germany.
Jazyk: angličtina
Zdroj: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG [J Dtsch Dermatol Ges] 2024 Nov; Vol. 22 (11), pp. 1499-1507. Date of Electronic Publication: 2024 Sep 12.
DOI: 10.1111/ddg.15512
Abstrakt: Background: The global incidence of skin cancer has steadily increased in recent years. Accordingly, patients require information on diagnosis and treatment options while dealing with the perceived impact of the diagnosis. In 2015, the German government enacted legislation under the Social Code (SGB V, § 27b), granting patients the right to obtain a second medical opinion.
Patients and Methods: Utilizing a standardized questionnaire, our study aims to explore whether patients diagnosed with skin cancer actively pursue a second medical opinion and to evaluate any potential disruptions to their daily lives. We collected a total of 714 completed questionnaires.
Results: The majority of those seeking a second opinion were diagnosed with malignant melanoma (96, 58%). Primary motivations for seeking a second opinion included seeking reassurance regarding treatment decisions and obtaining further information. Additionally, seeking a second opinion was correlated with a significantly lower internal locus of control, indicating a belief that their actions are not solely determined by their own abilities. Notably, we observed a greater impairment of daily life among younger participants and those with advanced cancer.
Conclusions: Overall, our study shows that second opinions often strengthened the patient-physician interaction and provided additional reassurance, especially in patients with a weak perception of control. Moreover, we found that the impairment of quality of life and both internal and external locus of control decrease significantly in advanced tumor stages. Hence, it is imperative to identify additional interventions aimed at bolstering internal resilience and locus of control, thereby enhancing patients' capacity to cope with their cancer diagnosis.
(© 2024 The Author(s). Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.)
Databáze: MEDLINE
Externí odkaz: